Literature DB >> 14602182

Influence of mechanical activation on the physical stability of salbutamol sulphate.

Katharina Brodka-Pfeiffer1, Peter Langguth, Peter Grass, Heribert Häusler.   

Abstract

In order to obtain the optimal particle size distribution for pharmaceutical powders in dry powder inhalers the particles have to be micronised. In most cases the process of micronisation is connected with a high input of energy which induces disorder and defects on the surface of the drug particles and as a result changes in the crystallinity. Consequently, changes in the physical stability of the powders may occur. To investigate changes on the physical stability of the powder, different analytical methods are used in the present investigation: laser diffraction, Differential Scanning Calorimetry (DSC), isothermal microcalorimetry and DVS-method.Air-jet-milling is one of the most frequently used techniques in the pharmaceutical industry, in order to obtain particles of respirable size. In the treatise described here the influence of the critical parameters of the process, i.e. feed pressure, grind pressure and feed rate is assessed for salbutamol sulphate. The grind pressure is of utmost importance with respect to particle size distribution and the physical powder stability. For salbutamol sulphate, ground with a MC Jetmill 50, a grind pressure of 6 bar has been found optimal. Pressures below 6 bar are not sufficient to produce the required reduction in particle size. The feed pressure and rate have negligible influence on the powder quality. Furthermore, the micronisation process is optimised to achieve respirable particles while minimising the amorphous content. A correlation between mechanical activation and the amount of the amorphous regions is showed clearly.Air-jet-milling has been compared to ball milling in this investigation. In pilot tests ball milling was not suitable to achieve the needed particle size distribution, however, it generates a specific quantity of amorphous material. With the help of specific amorphous regions in the powder, the sensitivity of the used methods for salbutamol sulphate can be examined.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14602182     DOI: 10.1016/s0939-6411(03)00134-6

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  8 in total

1.  Investigation into the influence of primary crystallization conditions on the mechanical properties and secondary processing behaviour of fluticasone propionate for carrier based dry powder inhaler formulations.

Authors:  Harshal A Kubavat; Jagdeep Shur; Graham Ruecroft; David Hipkiss; Robert Price
Journal:  Pharm Res       Date:  2011-12-09       Impact factor: 4.200

2.  The influence of secondary processing on the structural relaxation dynamics of fluticasone propionate.

Authors:  Roberto Depasquale; Sau L Lee; Bhawana Saluja; Jagdeep Shur; Robert Price
Journal:  AAPS PharmSciTech       Date:  2014-11-15       Impact factor: 3.246

3.  Anomalous particle size shift during post-milling storage.

Authors:  Wai Kiong Ng; Jin Wang Kwek; Reginald B H Tan
Journal:  Pharm Res       Date:  2007-11-29       Impact factor: 4.200

Review 4.  An overview on in situ micronization technique - An emerging novel concept in advanced drug delivery.

Authors:  K R Vandana; Y Prasanna Raju; V Harini Chowdary; M Sushma; N Vijay Kumar
Journal:  Saudi Pharm J       Date:  2013-05-29       Impact factor: 4.330

5.  The effect of acetaminophen nanoparticles on liver toxicity in a rat model.

Authors:  Esmaeil Biazar; S Mahdi Rezayat; Naser Montazeri; Khalil Pourshamsian; Reza Zeinali; Azadeh Asefnejad; Mehdi Rahimi; Mohammadmajid Zadehzare; Mehran Mahmoudi; Rohollah Mazinani; Mehdi Ziaei
Journal:  Int J Nanomedicine       Date:  2010-04-07

6.  Effect of the mechanical activation on size reduction of crystalline acetaminophen drug particles.

Authors:  Esmaeil Biazar; Ali Beitollahi; S Mehdi Rezayat; Tahmineh Forati; Azadeh Asefnejad; Mehdi Rahimi; Reza Zeinali; Mahmoud Ardeshir; Farhad Hatamjafari; Ali Sahebalzamani; Majid Heidari
Journal:  Int J Nanomedicine       Date:  2009-12-29

7.  Production of ultrafine sumatriptan succinate particles for pulmonary delivery.

Authors:  Zong-Yang Yang; Yuan Le; Ting-Ting Hu; Zhigang Shen; Jian-Feng Chen; Jimmy Yun
Journal:  Pharm Res       Date:  2008-06-26       Impact factor: 4.580

8.  Evidence for the existence of powder sub-populations in micronized materials: aerodynamic size-fractions of aerosolized powders possess distinct physicochemical properties.

Authors:  Sara Jaffari; Ben Forbes; Elizabeth Collins; Jiyi Khoo; Gary P Martin; Darragh Murnane
Journal:  Pharm Res       Date:  2014-12       Impact factor: 4.200

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.